Trial Profile
A Randomized Clinical Trial to Evaluate the Efficacy and Safety of 10mg Alfuzosin in the Treatment of Chronic Prostatitis / Chronic Pelvic Pain Syndrome (CP/CPPS) in Recently-Diagnosed and/or Newly-Symptomatic Alpha-blocker Naïve Patients
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 15 Jun 2020
Price :
$35
*
At a glance
- Drugs Alfuzosin (Primary)
- Indications Prostatitis
- Focus Therapeutic Use
- 18 Dec 2008 Results have been published in the New England Journal of Medicine.
- 12 Mar 2008 Status changed from in progress to completed. Updated from ClinicalTrials.gov.
- 11 Oct 2007 Status changed from recruiting to in progress.